Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...

SAN FRANCISCO -- Better indicators of high-grade atrioventricular (AV) conduction system abnormalities following transcatheter aortic valve replacement (TAVR) could be gleaned from an intraprocedural ...

SAN FRANCISCO, CA—Conduction abnormalities like complete heart block (CHB) and left bundle branch block (LBBB) remain common in today’s TAVI patients, with some facing pacemaker implantation or even ...

EAST PALESTINE –University of Kentucky College of Public Health environmental scientist Dr. Erin Haynes launched the second phase of a health study to track the epidemiological impacts on residents in ...

Shares of Eupraxia Pharmaceuticals rose after the company said the first patient in the Phase 2b trial of its eosinophilic esophagitis treatment has been dosed. The stock was up 9.3% at $5.90 in early ...

Directors of cardiac catheterization labs at top hospitals in the United States tend to have more financial connections to industry than their peers who aren’t in these roles, according to an analysis ...

Electrophysiology (EP) procedures are crucial in diagnosing and treating various heart rhythm disorders. They involve a doctor placing thin catheters into the heart to assess its electrical activity.

First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...